Medline Inc. reports results for the quarter ended June 30 - Earnings Summary
Medline Inc. reports results for the quarter ended June 30 - Earnings Summary
Medline Inc. MDLN.OQ reported quarterly adjusted earnings of 50 cents per share for the quarter ended June 30. The mean expectation of twenty six analysts for the quarter was for earnings of 32 cents per share. Wall Street expected results to range from 29 cents to 38 cents per share.
Revenue was $7.69 billion; analysts expected $7.51 billion.
Medline Inc.'s reported EPS for the quarter was 7 cents.
The company reported quarterly net income of $60 million.
Medline Inc. shares had risen by 6.6% this quarter and gained 0.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 2.8% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."
Wall Street's median 12-month price target for Medline Inc. is $52.00, about 19.2% above its last closing price of $42.04
This summary was machine generated from LSEG data August 5 at 01:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.32 | 0.50 | Beat |
Mar. 31 2026 | 0.30 | 0.33 | Beat |
Dec. 31 2025 | 0.25 | 0.43 | Beat |
Recent news on Medline
See all newsU.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Medline Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Medline Reports Second Quarter And First Six Months 2026 Results
Medline Q2 profit sinks on Tracy fire-related charges